Evidence map›Paper›PMID 33967552›Full record

ReviewWorld journal of gastroenterology2021

Paediatric gastrointestinal disorders in SARS-CoV-2 infection: Epidemiological and clinical implications.

Mohammed Al-Beltagi, Nermin Kamal Saeed, Adel Salah Bediwy, Yasser El-Sawaf

Registry-linked trialOpen access · hybridAbstract readReview
In one paragraph

Review in World journal of gastroenterology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05582512 (Clinical Characteristics and Long Term Impact on Pediatric COVID-19 in Taiwan), which is not on this map. Cited by 22 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 2 pooled it
1.8field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05582512 recruitingnot on this mapstarted 2022, after this paper: background citation

Clinical Characteristics and Long Term Impact on Pediatric COVID-19 in Taiwan

Typeobservational_patient_registrySponsorNational Taiwan University HospitalRan2022 to 2027Enrolled3,000ConditionsLong Covid19, COVID-19 Pneumonia, Multisystem Inflammatory Syndrome in ChildrenArmssequelae tracking
3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 2 syntheses or guidelines pooled it, 31 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Mohammed Al-BeltagiDepartment of Pediatric, Faculty of Medicine, Tanta University, Tanta 31527, Algharbia, Egypt.
Nermin Kamal SaeedMicrobiology Section, Pathology Department, Salmaniya Medical Complex, Manama 12, Bahrain.
Adel Salah BediwyDepartment of Chest Diseases, Tanta University, Tanta 31527, Algharbia, Egypt.
Yasser El-SawafDepartment of Tropical Medicine, Tanta University, Tanta 31527, Algharbia, Egypt.
Tanta University · EGSalmaniya Medical Complex · BH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The coronavirus disease 2019 (COVID-19) pandemic is a threat worldwide for individuals of all ages, including children. Gastrointestinal manifestations could be the initial presenting manifestation in many patients, especially in children. These symptoms are more common in patients with severe disease than in patients with non-severe disease. Approximately 48.1% of patients had a stool sample that was positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral RNA. Children typically form 1%-8% of all laboratory-confirmed cases of SARS-CoV-2. Gastrointestinal manifestations of COVID-19 in children are not rare, with a prevalence between 0 and 88%, and a wide variety of presentations, including diarrhoea, vomiting, and abdominal pain, can develop before, with or after the development of respiratory symptoms. Atypical manifestations such as appendicitis or liver injury could also appear, especially in the presence of multisystem inflammatory disease. In this review, we discussed the epidemiology of COVID-19 gastrointestinal diseases in children as well as their implications on the diagnosis, misdiagnosis, prognosis, and faecal-oral transmission route of COVID-19 and the impact of gastrointestinal diseases on the gut microbiome, child nutrition, and disease management.

Indexed as

COVID-19Gastrointestinal DiseasesChildHumansPandemicsSARS-CoV-2Systemic Inflammatory Response SyndromeChildrenCOVID-19DysbiosisFaecal-oral transmissionGastrointestinal diseasesSARS-CoV-2

Identifiers

PMID33967552
PMCPMC8072196
OpenAlexW3156424591

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.